Incremental prognostic value of SPECT-MPI in chronic kidney disease: A reclassification analysis

Amjad M Ahmed1, Waqas T Qureshi2, Wesley T O'Neal2

  • 1King Abdulaziz Cardiac Center, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, P.O. Box 22490, Riyadh, 11426, Saudi Arabia.

Insights

Single-photon emission computerized tomography-myocardial perfusion imaging (SPECT-MPI) detects perfusion defects that independently predict cardiovascular mortality in chronic kidney disease (CKD) patients. This imaging significantly improves risk stratification beyond traditional factors.

Area of Science:

  • Cardiology
  • Nephrology
  • Nuclear Medicine

Background:

  • Traditional cardiovascular (CV) risk factors have limited predictive value for CV mortality in patients with chronic kidney disease (CKD).
  • CKD is defined as creatinine clearance less than 60 mL/minute per 1.73 m².
  • There is a need for improved risk stratification in CKD patients.

Purpose of the Study:

  • To evaluate the incremental and independent prognostic value of single-photon emission computerized tomography-myocardial perfusion imaging (SPECT-MPI).
  • To assess SPECT-MPI's predictive capability across the continuum of renal function in CKD patients.
  • To determine if SPECT-MPI improves risk prediction beyond traditional CV risk factors and GFR.

Main Methods:

  • Retrospective study of 11,518 patients undergoing SPECT-MPI.
  • Primary endpoint: composite of cardiac death and non-fatal myocardial infarction (CD/MI).
  • Analysis of total perfusion defect (TPD) using Cox regression, adjusting for CV risk factors and GFR, and assessing incremental predictive value with Harrell's c-index, NRI, and IDI.

Main Results:

  • Over a median 5-year follow-up, 14.5% of patients experienced CD/MI.
  • Perfusion defects on SPECT-MPI were independently associated with increased CD/MI risk (HR=2.10, p<.001), even after adjusting for CV risk factors and GFR.
  • TPD significantly improved discriminatory ability (AUC increased from 0.725 to 0.784, p<.0001) and risk stratification (NRI=14%, relative IDI=60%, p<.001) compared to traditional factors.

Conclusions:

  • SPECT-MPI-detected perfusion defects independently and incrementally predict CD/MI risk in patients across the spectrum of renal function.
  • SPECT-MPI offers significant prognostic value beyond traditional CV risk factors and GFR in CKD patients.
  • These findings support the use of SPECT-MPI for enhanced risk stratification in CKD.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
285
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
434
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
561
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.2K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
854
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
920